Fortis Unveils ‘Hembot’, the First Humanoid Robot for Healthcare

The robot was meant to demonstrate how humanoid systems may support hospitals in areas such as patient guidance, navigation, clinical information support, and monitoring assistance, among others.

Fortis Memorial Research Institute (FMRI) has unveiled Hembot, the first life-sized humanoid robot meant for healthcare settings.

The robot is built on the NVIDIA Jetson Orin platform and, capable of 100 trillion AI operations per second.

It was introduced to demonstrate how humanoid systems may support hospitals in areas such as patient guidance, navigation, clinical information support, monitoring assistance, and general engagement in OPDs and waiting areas within clinical settings.

Reportedly, Hembot also showcased its ability to perform synchronised movements while responding to commands and interactions.

According to FMRI, this demonstration reflects its vision for an AI-augmented future in healthcare and was intended to provide a glimpse into how robotics could become part of frontline hospital operations.

Beyond the robot’s launch, FMRI also featured discussions on advances in genomics, artificial intelligence, and cell-based therapies in hematology.

Experts highlighted how genetic sequencing and mutation profiling are increasingly used to support the diagnosis of blood cancers and inherited hematological disorders.

Dr. Rahul Bhargava, Principal Director & Chief, Hematology, Hemato Oncology & Bone Marrow Transplant, FMRI, said, “At Fortis, we have built one of India’s most comprehensive hematology ecosystems, bringing together genomics, advanced diagnostics, cell therapies, and AI-driven tools under one roof.”

The speakers also observed that scientific advances are improving patient care, including faster cancer detection using AI tools, more precise genetic reporting through advanced genomics, emerging options such as CAR-T, and the use of robotics for clinical.

Reflecting his thoughts on this regard, Yash Rawat, Senior Vice President & SBU Head, FMRI, said, “FMRI is emerging as India’s precision-hematology hub. With genomics-led workflows, AI-assisted diagnostics, next-generation therapies like CAR-T, and now humanoid robotics, Fortis Gurugram is shaping the future of integrated, high-end hematology care.”

Further, the speakers highlighted that genomics-based donor matching is helping make bone marrow transplants safer, while data-driven, personalised treatment approaches are contributing to better clinical outcomes.

Stay tuned for more such updates on Digital Health News